Epigral LtdEpigral LtdEpigral Ltd

Epigral Ltd

No trades
No trades

Fundamentals and stats

Top segments and regional performance

Last year, the company generated ‪25.27 B‬ INR, the most of which — ‪24.44 B‬ INR — came from its top-performing segment, Chlor Alkali & Its Derivatives, compared to ‪24.67 B‬ INR the previous year. The greatest contribution came from India, which accounted for ‪24.18 B‬ INR last year, with ‪23.45 B‬ INR the year before.

By source
By country